Chất làm đầy da
REVANESSE mã hàng do ALLPARA lưu kho cho mục đích chuyên môn, nhập trực tiếp và có chứng nhận cho mỗi lô giao.
Đạt dấu CE
SKU 11118
Revanesse Lips™+
Còn hàng
Dung tích
2 x 1,2 mL
Nhà sản xuất
Prollenium Medical Technologies Inc.
Xuất xứ
Canada
Giá bán sỉ và lịch sử giá chỉ dành cho tài khoản đã xác minh
allpara cung cấp sản phẩm cho người hành nghề có giấy phép. Đăng nhập hoặc đăng ký tài khoản B2B để xem giá theo thời gian thực, các mức giá theo số lượng và lịch sử giá.
Revanesse Lips+ is a biocompatible, biodegradable, non-pyrogenic, sterile, injectable viscoelastic hydrogel, clear and colourless, from Prollenium Medical Technologies in Aurora, Canada, developed for lip augmentation. It is indicated for submucosal implantation in patients 22 years of age or older and is FDA approved under PMA P160042/S010. The gel carries 25 mg/mL of bioresorbable, BDDE cross-linked hyaluronic acid, produced by the Streptococcus species of bacteria, with 0.3% lidocaine and is intended for professional use. A box holds two 1.2 mL glass syringes and two 0.5 inch 30-gauge sterile needles.
*Note: This product is FDA-approved in the United States. Regulatory status and availability may vary by country. Please contact ALLPARA to confirm availability for your market.
Lợi ích chính của Revanesse Lips™+
- BDDE cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
- Indicated specifically for lip augmentation by submucosal implantation
- FDA approved under PMA P160042/S010
- Supplied with two 0.5 inch 30-gauge sterile needles
- Supplied as two 1.2 mL glass syringes per box
- Hyaluronic acid produced by the Streptococcus species of bacteria
- Removable label portion for the patient record
Chỉ định và sử dụng chuyên môn
Chỉ định chính
- Lip augmentation by submucosal implantation
Sử dụng chuyên môn
For professional use. Revanesse Lips+ is administered by qualified physicians trained in the proper injection technique, and is not for retail sale or self-administration. It is placed by submucosal implantation in the lip using the 0.5 inch 30-gauge needles supplied. Its approval was supported by two clinical studies: a multicentre, double-blind, randomised, controlled treatment study enrolling 158 subjects over 10 months, and a multicentre, open-label retreatment study of 84 of those subjects over a further 8 months, with lip fullness assessed on the 5-point Lip Fullness Grading Scale.
Vùng điều trị
- Lips
Đối tượng bệnh nhân
Indicated for patients 22 years of age or older seeking lip augmentation. It must not be used in patients who develop hypertrophic scarring or keloid formation, in patients with evidence of scars at the intended treatment sites, in patients with acne or other inflammatory skin disease, in patients with multiple severe allergies or a history of allergy, or in patients with unattainable expectations. It must never be used in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion treatments, or with over-the-counter or prescription wrinkle treatments within 4 weeks of treatment.
Cơ chế hoạt động của Revanesse Lips™+
Lips+ is placed submucosally in the lip, where the cross-linked hyaluronic acid hydrogel adds volume directly. It is the only reference in the Revanesse range with an indication written specifically and solely for lip augmentation, which is reflected in its delivery: a fine 0.5 inch 30-gauge needle rather than the 27G used by the deeper-placed grades. The 0.3% lidocaine is present for injection comfort. Each syringe carries a removable portion of its label that can be affixed to the patient record for traceability.
Vì sao nên đặt hàng tại Allpara
Allpara cung cấp sản phẩm REVANESSE chính hãng, đã được xác minh, từ các nhà cung cấp được tuyển chọn, với khả năng truy xuất lô đầy đủ và hỗ trợ chuyên môn. Chúng tôi phục vụ các phòng khám và chuyên gia thẩm mỹ với sản phẩm đạt chứng nhận CE, giao hàng nhanh khắp EU từ kho tại EU và giá chuyên nghiệp cạnh tranh. Ưu tiên của chúng tôi là sự an toàn, hài lòng và kết quả của bệnh nhân của bạn, cùng dịch vụ hậu mãi tận tâm để bạn hoàn toàn yên tâm.
Câu hỏi thường gặp
How does Revanesse Lips™+ differ from the other Revanesse references?
Its indication is written solely for lip augmentation, by submucosal implantation, in patients 22 years of age or older. It shares the 25 mg/mL BDDE cross-linked hyaluronic acid and 0.3% lidocaine of Revanesse Contour™+ and Revanesse Sculpt™+, but is supplied with finer 0.5 inch 30-gauge needles rather than 27G.
What clinical evidence supports Revanesse Lips+?
Two studies formed the basis of the PMA approval decision: a multicentre, double-blind, randomised, controlled treatment study of 158 subjects lasting 10 months, and a multicentre, open-label retreatment study of 84 of those subjects lasting a further 8 months. Effectiveness was measured as change in overall Lip Fullness Grading Scale score for both lips together.
Thêm sản phẩm từ Prollenium Medical Technologies
Lựa chọn thay thế cho phòng khám
/ Đã xem gần đây
Tiếp tục từ nơi bạn dừng lại
Revanesse Lips™+
Còn hàng
Đạt dấu CE
Giá chỉ dành cho tài khoản đã xác minh
Đăng nhập hoặc đăng ký tài khoản B2B để xem giá của bạn.
Đăng ký tài khoản B2B
Revanesse Lips+ is a biocompatible, biodegradable, non-pyrogenic, sterile, injectable viscoelastic hydrogel, clear and colourless, from Prollenium Medical Technologies in Aurora, Canada, developed for lip augmentation. It is indicated for submucosal implantation in patients 22 years of age or older and is FDA approved under PMA P160042/S010. The gel carries 25 mg/mL of bioresorbable, BDDE cross-linked hyaluronic acid, produced by the Streptococcus species of bacteria, with 0.3% lidocaine and is intended for professional use. A box holds two 1.2 mL glass syringes and two 0.5 inch 30-gauge sterile needles.
*Note: This product is FDA-approved in the United States. Regulatory status and availability may vary by country. Please contact ALLPARA to confirm availability for your market.
Lợi ích chính của Revanesse Lips™+
- BDDE cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine
- Indicated specifically for lip augmentation by submucosal implantation
- FDA approved under PMA P160042/S010
- Supplied with two 0.5 inch 30-gauge sterile needles
- Supplied as two 1.2 mL glass syringes per box
- Hyaluronic acid produced by the Streptococcus species of bacteria
- Removable label portion for the patient record
Chỉ định và sử dụng chuyên môn
Chỉ định chính
- Lip augmentation by submucosal implantation
Sử dụng chuyên môn
For professional use. Revanesse Lips+ is administered by qualified physicians trained in the proper injection technique, and is not for retail sale or self-administration. It is placed by submucosal implantation in the lip using the 0.5 inch 30-gauge needles supplied. Its approval was supported by two clinical studies: a multicentre, double-blind, randomised, controlled treatment study enrolling 158 subjects over 10 months, and a multicentre, open-label retreatment study of 84 of those subjects over a further 8 months, with lip fullness assessed on the 5-point Lip Fullness Grading Scale.
Vùng điều trị
- Lips
Đối tượng bệnh nhân
Indicated for patients 22 years of age or older seeking lip augmentation. It must not be used in patients who develop hypertrophic scarring or keloid formation, in patients with evidence of scars at the intended treatment sites, in patients with acne or other inflammatory skin disease, in patients with multiple severe allergies or a history of allergy, or in patients with unattainable expectations. It must never be used in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion treatments, or with over-the-counter or prescription wrinkle treatments within 4 weeks of treatment.
Cơ chế hoạt động của Revanesse Lips™+
Lips+ is placed submucosally in the lip, where the cross-linked hyaluronic acid hydrogel adds volume directly. It is the only reference in the Revanesse range with an indication written specifically and solely for lip augmentation, which is reflected in its delivery: a fine 0.5 inch 30-gauge needle rather than the 27G used by the deeper-placed grades. The 0.3% lidocaine is present for injection comfort. Each syringe carries a removable portion of its label that can be affixed to the patient record for traceability.
Vì sao nên đặt hàng tại Allpara
Allpara cung cấp sản phẩm REVANESSE chính hãng, đã được xác minh, với khả năng truy xuất lô đầy đủ, hàng đạt chứng nhận CE, giao hàng nhanh khắp EU và hỗ trợ hậu mãi chuyên nghiệp.
Câu hỏi thường gặp
How does Revanesse Lips™+ differ from the other Revanesse references?
Its indication is written solely for lip augmentation, by submucosal implantation, in patients 22 years of age or older. It shares the 25 mg/mL BDDE cross-linked hyaluronic acid and 0.3% lidocaine of Revanesse Contour™+ and Revanesse Sculpt™+, but is supplied with finer 0.5 inch 30-gauge needles rather than 27G.
What clinical evidence supports Revanesse Lips+?
Two studies formed the basis of the PMA approval decision: a multicentre, double-blind, randomised, controlled treatment study of 158 subjects lasting 10 months, and a multicentre, open-label retreatment study of 84 of those subjects lasting a further 8 months. Effectiveness was measured as change in overall Lip Fullness Grading Scale score for both lips together.
Thêm sản phẩm từ Prollenium Medical Technologies
Xem nhà sản xuất →* Sản phẩm dùng cho chuyên môn. Bao bì có thể khác nhau tùy theo lô hoặc thị trường. Vui lòng tham khảo hướng dẫn sử dụng kèm theo để biết đầy đủ cách dùng và chống chỉ định.